Healthcare boost for Pengana

ESG outperformance depends on manager quality

The Cinderella of real estate investments

Which equity sectors managed to make returns?

Pengana boosts healthcare weight to 60%

Biotechnology firms to draw investors post-pandemic

Platinum cuts net position to 60% amid COVID-19 fallout

Biotech and healthcare funds unable to escape global sell-off

The healthcare stock winning from COVID-19

The Aussie healthcare stock outpacing rivals with near 700% returns

Low-debt companies driving returns for ESG investors

Searching for Value When Growth Is King

Don’t use super to plug Govt policy gaps

‘For profit’ funds deserve to remain in superannuation

ETF Securities launches CURE ETF